Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


28.05.2018

3 Clin Infect Dis
1 J Infect
13 J Infect Dis
1 Lancet
1 Lancet Infect Dis
1 Nat Med
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A
20 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. MCLAUGHLIN JM, Jiang Q, Isturiz RE, Sings HL, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
    Clin Infect Dis. 2018 May 21. pii: 5000157. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. BURKE RM, Tate JE, Dahl RM, Aliabadi N, et al
    Rotavirus Vaccination Is Associated with Reduced Seizure Hospitalization Risk Among Commercially Insured U.S. Children.
    Clin Infect Dis. 2018 May 16. pii: 4996816. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. LAWN JE, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, et al
    Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?
    Clin Infect Dis. 2017;65.
    PubMed     Text format     Abstract available


    J Infect

  4. PT P, B M, Fgj C
    BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing.
    J Infect. 2018 May 17. pii: S0163-4453(18)30127.
    PubMed     Text format     Abstract available


    J Infect Dis

  5. JARRETT OD, Seward JF, Fombah AE, Lindblad R, et al
    Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  6. CARTER RJ, Idriss A, Widdowson MA, Samai M, et al
    Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  7. FOMBAH AE, Goldstein ST, Jarrett OD, Jalloh MI, et al
    Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  8. EDEM-HOTAH J, McDonald W, Abu PM, Luman ET, et al
    Utilizing Nurses to Staff an Ebola Vaccine Clinical Trial in Sierra Leone during the Ebola Outbreak.
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  9. JUSU MO, Glauser G, Seward JF, Bawoh M, et al
    Rapid Establishment of a Cold Chain Capacity of -60 degrees C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  10. VAN DAMME P
    Long-term Protection After Hepatitis B Vaccine.
    J Infect Dis. 2016.
    PubMed     Text format    

  11. SCHUCHAT A, Seward JF, Goldstein ST, Mahon BE, et al
    Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2018;217.
    PubMed     Text format    

  12. SAMAI M, Seward JF, Goldstein ST, Mahon BE, et al
    The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSVG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  13. BERNSTEIN DI
    Rotavirus Vaccines: Mind Your Ps and Gs.
    J Infect Dis. 2018 May 22. pii: 5001445. doi: 10.1093.
    PubMed     Text format    

  14. CONTEH MA, Goldstein ST, Wurie HR, Gidudu J, et al
    Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  15. CARTER RJ, Senesi RGB, Dawson P, Gassama I, et al
    Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  16. KABINEH AK, Carr W, Motevalli M, Legardy-Williams J, et al
    Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience.
    J Infect Dis. 2018;217.
    PubMed     Text format     Abstract available

  17. ROCZO-FARKAS S, Kirkwood CD, Cowley D, Barnes GL, et al
    The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data.
    J Infect Dis. 2018 May 22. pii: 5001444. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet

  18. QADRI F, Azad AK, Flora MS, Khan AI, et al
    Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh.
    Lancet. 2018;391:1877-1879.
    PubMed     Text format    


    Lancet Infect Dis

  19. ANDERSON KB, Endy TP, Thomas SJ
    The dynamic role of dengue cross-reactive immunity: changing the approach to defining vaccine safety and efficacy.
    Lancet Infect Dis. 2018 May 18. pii: S1473-3099(18)30126.
    PubMed     Text format     Abstract available


    Nat Med

  20. VACCARI M, Fourati S, Gordon SN, Brown DR, et al
    HIV vaccine candidate activation of hypoxia and the inflammasome in CD14(+) monocytes is associated with a decreased risk of SIVmac251 acquisition.
    Nat Med. 2018 May 21. pii: 10.1038/s41591-018-0025.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  21. TAO Y, Shea K, Ferrari M
    Logistical constraints lead to an intermediate optimum in outbreak response vaccination.
    PLoS Comput Biol. 2018;14:e1006161.
    PubMed     Text format     Abstract available


    PLoS One

  22. NEIRA V, Allerson M, Corzo C, Culhane M, et al
    Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.
    PLoS One. 2018;13:e0197600.
    PubMed     Text format     Abstract available

  23. HUANG Z, Sun X, Wagner AL, Ren J, et al
    Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China.
    PLoS One. 2018;13:e0197437.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  24. TZENG SY, McHugh KJ, Behrens AM, Rose S, et al
    Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response.
    Proc Natl Acad Sci U S A. 2018 May 21. pii: 1720970115.
    PubMed     Text format     Abstract available


    Vaccine

  25. JONKER EFF, van Ravenhorst MB, Berbers GAM, Visser LG, et al
    Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30704.
    PubMed     Text format     Abstract available

  26. BUTTENHEIM AM, Jones M, Mckown C, Salmon D, et al
    Conditional admission, religious exemption type, and nonmedical vaccine exemptions in California before and after a state policy change.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30670.
    PubMed     Text format     Abstract available

  27. CHUAI X, Xie B, Chen H, Tan X, et al
    The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30681.
    PubMed     Text format     Abstract available

  28. LI T, Wang H, Lu Y, Li Q, et al
    Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.
    Vaccine. 2018 May 15. pii: S0264-410X(18)30674.
    PubMed     Text format     Abstract available

  29. XU W, Zhang Z, Nfon C, Yang M, et al
    Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Vaccine. 2018 May 15. pii: S0264-410X(18)30665.
    PubMed     Text format     Abstract available

  30. CAPEDING MR, Teshome S, Saluja T, Syed KA, et al
    Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
    Vaccine. 2018 May 15. pii: S0264-410X(18)30658.
    PubMed     Text format     Abstract available

  31. APAYDIN KZ, Fontenot HB, Shtasel D, Dale SK, et al
    Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30217.
    PubMed     Text format     Abstract available

  32. HERBERT JA, Kay EJ, Faustini SE, Richter A, et al
    Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30656.
    PubMed     Text format     Abstract available

  33. SCHNAITH AM, Evans EM, Vogt C, Tinsay AM, et al
    An innovative medical school curriculum to address human papillomavirus vaccine hesitancy.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30621.
    PubMed     Text format     Abstract available

  34. PAGLIUSI S, Dennehy M, Kim H
    Vaccines, inspiring innovation in health.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30655.
    PubMed     Text format     Abstract available

  35. YANG YT, Silverman RD
    Mandatory influenza vaccination and religious accommodation for healthcare workers: Lessons from recent legal challenges.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30714.
    PubMed     Text format    

  36. JACKSON LA, Rupp R, Papadimitriou A, Wallace D, et al
    A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30635.
    PubMed     Text format     Abstract available

  37. DBAIBO G, Tinoco Favila JC, Traskine M, Jastorff A, et al
    Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study.
    Vaccine. 2018 May 18. pii: S0264-410X(18)30666.
    PubMed     Text format     Abstract available

  38. DE MENEZES MARTINS R, Maia MLS, de Lima SMB, de Noronha TG, et al
    Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.
    Vaccine. 2018 May 18. pii: S0264-410X(18)30661.
    PubMed     Text format     Abstract available

  39. CHEN Y, Ma F, Xu Y, Chu X, et al
    Vaccines and the risk of acute disseminated encephalomyelitis.
    Vaccine. 2018 May 18. pii: S0264-410X(18)30703.
    PubMed     Text format     Abstract available

  40. GRIEVES JL, Yin Z, Garcia-Sastre A, Mena I, et al
    A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.
    Vaccine. 2018 May 17. pii: S0264-410X(18)30609.
    PubMed     Text format     Abstract available

  41. FERNANDO GJP, Hickling J, Jayashi Flores CM, Griffin P, et al
    Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch).
    Vaccine. 2018 May 17. pii: S0264-410X(18)30673.
    PubMed     Text format     Abstract available

  42. KONNO R, Konishi H, Sauvaget C, Ohashi Y, et al
    Effectiveness of HPV vaccination against high grade cervical lesions in Japan.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30668.
    PubMed     Text format     Abstract available

  43. DILLNER J, Nygard M, Munk C, Hortlund M, et al
    Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30626.
    PubMed     Text format     Abstract available

  44. LOGAN J, Nederhoff D, Koch B, Griffith B, et al
    'What have you HEARD about the HERD?' Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate?
    Vaccine. 2018 May 19. pii: S0264-410X(18)30657.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: